Prosecution Insights
Last updated: October 25, 2026

Leo Cancer Care Inc.

Technology areas: Transportation, E-Commerce & Mechanical Systems • Medical Devices & Mechanical Engineering

2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Analysis

Leo Cancer Care Inc. has 1 pending office action in Medical Devices & Mechanical Engineering. The matter is assigned to 1 distinct examiner and 1 distinct art unit.

PATEL, TARLA R is the busiest examiner, with 1 pending matter. The profile supports a focused prosecution strategy centered on the assigned examiner, technical group, claim scope, and cited-art record.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
1
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)2 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
PATEL, TARLA R 1 73.8% +30.7%
SANTOS, ROBERT G 1 73.1% +34.9%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
19161361 PATIENT SUPPORT BOARD PATEL, TARLA R —
19249689 PATIENT POSITIONING SYSTEM SANTOS, ROBERT G —

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
19161361 PATIENT SUPPORT BOARD PATEL, TARLA R —
19249689 PATIENT POSITIONING SYSTEM SANTOS, ROBERT G —

Top Art Units

Art UnitApps
3786 1
3673 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19161361 PATIENT SUPPORT BOARD PATEL, TARLA R 3786 §102§103 Non-Final OA — Pending Sep 02, 2025
19249689 PATIENT POSITIONING SYSTEM SANTOS, ROBERT G 3673 §102§103§112Other Final Rejection — Pending Jun 25, 2025

Managing Leo Cancer Care Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Leo Cancer Care Inc. have?

Leo Cancer Care Inc. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.

Which USPTO examiner handles the most Leo Cancer Care Inc. applications?

Tarla R Patel has the most, with 1 of Leo Cancer Care Inc.'s pending office actions.

What technology area are Leo Cancer Care Inc.'s patent applications in?

Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month